Cargando…
Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders
Brain amyloid deposition is an early pathological event in Alzheimer’s disease (AD), and abnormally low levels amyloid-β(42) peptide (Aβ(42)) in cerebrospinal fluid (CSF) can be detected in preclinical AD. To identify the genetic determinants that regulate the rate of CSF Aβ(42) decline among non-de...
Autores principales: | Dou, Kai-Xin, Zhang, Can, Tan, Chen-Chen, Xu, Wei, Li, Jie-Qiong, Cao, Xi-Peng, Tan, Lan, Yu, Jin-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710044/ https://www.ncbi.nlm.nih.gov/pubmed/31370031 http://dx.doi.org/10.18632/aging.102125 |
Ejemplares similares
-
Genome-wide association study of hippocampal atrophy rate in non-demented elders
por: Guo, Yu, et al.
Publicado: (2019) -
Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022) -
MAPT rs242557 variant is associated with hippocampus tau uptake on (18)F-AV-1451 PET in non-demented elders
por: Shen, Xue-Ning, et al.
Publicado: (2019) -
Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders
por: Wang, Zuo-Teng, et al.
Publicado: (2019) -
Impact of SORL1 genetic variations on MRI markers in non-demented elders
por: Yin, Rui-Hua, et al.
Publicado: (2016)